Uracil derivatives as AXL and c-MET kinase inhibitors

摘要

The present invention provides compounds of Formula I Rb N N, E Rd D Y 0 0 Ra W R1a Formula I or pharmaceutically acceptable salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, Ria, Rib, Ric,Y, R3, X, E and G are as defined herein, methods of treatment and uses thereof.